Corvus Pharma Stock (NASDAQ:CRVS), Quotes and News Summary

Q: What sector and industry does Corvus Pharma (CRVS) operate in?

Corvus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Corvus Pharma Stock (NASDAQ: CRVS) stock price, news, charts, stock research, profile.

Open	$2.100
Close	$2.030
Volume / Avg.	649.663K / 247.703K
Day Range	1.970 - 2.190
52 Wk Range	1.050 - 4.190
Market Cap	$100.887M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	63
Short Interest	3.7%
Days to Cover	7.52

Recent News

Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some other stocks moving in pre-market trading.

Avi Kapoor

Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company's subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking for alternatives to safes made by Liberty Safe.

Lisa Levin

Corvus Pharmaceuticals Eyes Expansion Of Blood Cancer Therapy but Resource Limitations Pose Challenge: Oppenheimer

Oppenheimer has initiated coverage on Corvus Pharmaceuticals Inc (NASDAQ: CRVS) with an Outperform rating and a

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Corvus Pharma (CRVS) stock?

You can purchase shares of Corvus Pharma (NASDAQ: CRVS) through any online brokerage.

View our list of the best stock brokerages.

Who are Corvus Pharma's (CRVS) competitors?

Other companies in Corvus Pharma’s space includes: Anixa Biosciences (NASDAQ:ANIX), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Connect Biopharma Hldgs (NASDAQ:CNTB) and Burning Rock Biotech (NASDAQ:BNR).

What is the target price for Corvus Pharma (CRVS) stock?

The latest price target for Corvus Pharma (NASDAQ: CRVS) was reported by Oppenheimer on Tuesday, May 7, 2024. The analyst firm set a price target for 8.00 expecting CRVS to rise to within 12 months (a possible 288.86% upside). 7 analyst firms have reported ratings in the last year.

Current Stock Price for Corvus Pharma (CRVS)?

The stock price for Corvus Pharma (NASDAQ: CRVS) is $2.0573 last updated Today at May 9, 2024 at 4:39 PM EDT.

Does Corvus Pharma (CRVS) pay a dividend?

There are no upcoming dividends for Corvus Pharma.

When is Corvus Pharma (NASDAQ:CRVS) reporting earnings?

Corvus Pharma’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Is Corvus Pharma (CRVS) going to split?

There is no upcoming split for Corvus Pharma.

What sector and industry does Corvus Pharma (CRVS) operate in?

Corvus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-